title: [Non-tuberculous bacterial pleuropneumopathies in children in Abidjan].
abstract: We carried out a retrospective study to investigate epidemiological and clinical aspects of patient management in a hospital environment. We studied 90 cases of non-tuberculous bacterial pleuropneumopathies in children, observed over a 5-year period, from January 1 1991 to December 31 1995, at the Pediatric Medical Unit of Yopougon University Hospital. Diagnosis was based on the association of an infectious syndrome with respiratory and digestive disorders, and was confirmed by X ray. Bacteria were isolated from pleural pus and identified in fifty-one cases. Non-tuberculous bacterial pleuropneumopathies accounted for 5.22% of all pneumopathies in children, and the sex ratio for the patients affected was 1.9. Protein and energy malnutrition, anemia, being very young and climatic factors (harmattan and rainy seasons) were identified as major risk factors. The three main bacteria identified were Staphylococcus aureus (21 cases), Streptococcus pneumoniae (19 cases) and Haemophilus influenzae (6 cases). In this series of patients, 20% of the Staphylococcus aureus strains isolated were methicillin-resistant. Patients were generally treated with a combination of penicillin A and M and aminoside, with or without a pleural drain. The outcome was favorable in 77.8% of cases, with no severe sequelae detected by X ray. Six of the children died. Bacterial pneumopathies are still common in Sub-Saharan Africa and the patient being very young is indicative of a poor prognosis.
authors.affiliation: Service de pédiatrie, CHU de Yopougon, 21 BP 632, Abidjan 21, Côte d'Ivoire.
authors.forename: F
authors.initials: F
authors.lastname: Amon-Tanoh-Dick
authors.forename: A M
authors.initials: AM
authors.lastname: Timité-Konan
authors.forename: M M
authors.initials: MM
authors.lastname: Biafry
authors.forename: Y L
authors.initials: YL
authors.lastname: Adonis-Koffy
authors.forename: A M
authors.initials: AM
authors.lastname: N'Goan-Domoua
authors.forename: K V
authors.initials: KV
authors.lastname: Assé
authors.forename: C
authors.initials: C
authors.lastname: Anderson-Koua
authors.forename: E
authors.initials: E
authors.lastname: Lasme-Guillao
mesh_terms: D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology*; D002675:Child, Preschool; D007560:Cote d'Ivoire / Q000453:epidemiology; D005260:Female; D006192:Haemophilus Infections / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008171:Lung Diseases / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D010995:Pleural Diseases / Q000188:drug therapy / Q000453:epidemiology*; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000453:epidemiology*; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy / Q000453:epidemiology; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D012737:Sex Factors
chemical_list: D000900:Anti-Bacterial Agents